Shimaa Sayed
Fellowship-Trained, Egyptian Fellowship of Clinical Pharmacy. Fellowship-Trained, Egyptian Fellowship of Healthcare Management. Manager of Medication Management Unit, Egyptian Drug Authority (EDA). Member of National Antimicrobial team, Egyptian Drug Authority (EDA). Clinical Pharmacy (pediatric ICU) Instructor, General Organization For Teaching Hospitals and Institutes (GOTHI). Former Clinical Pharmacist, Cairo University Specialized Pediatric Hospital (Abo-Elreesh Elyabany). Former Clinical Pharmacy Inspector, General Organization For Teaching Hospitals and Institutes (GOTHI).

First,  vancomycin allergy is rara and the commen scenario is red man syndrome which can be avoided by slow infusion second, a new study mentioned daptomycin as alternative but we need further clinical...

View Question
1 Vote Selected

Infants and Children <8 year: Use  in patients <8 years is not recommended due to adverse effects on tooth development and uncertain dosing; however, use has been described in scenarios where alternative...

View Question
1 Vote Selected

Yes, high dose of ampicillin sulbactam is suggested  as a component  of combination therapy for carbapenem resistant acinitobacter baumannii due to sulbactam's unique activity against acinitobacter baumannii...

View Question
1 Vote Selected

Asimple addition to dr hossam's answer regarding the rate of administration [  In elderly patients or those with pre-existing cardiac disease, consider infusing at a rate 25mg/min and titrate accordingly...

View Question
1 Vote

Third, vancomycin added due to the high incediance of resistant s.pneumonia so if the gram stain exclude this microorganism, no need to use vancomycin

View Question
0 Votes